Year To Quarter End Statement Of Income

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7353432

Concept 2023-04-01 to
2023-12-31
2023-04-01 to
2023-12-31
2023-04-01 to
2023-12-31
2023-04-01 to
2023-12-31
2023-04-01 to
2023-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
Year to quarter end statement of income
Statement of income
Net sales
54,685,000,000 JPY
54,685,000,000 JPY
JPY
52,864,000,000 JPY
1,821,000,000 JPY
55,573,000,000 JPY
JPY
55,573,000,000 JPY
53,753,000,000 JPY
1,820,000,000 JPY
Cost of sales
24,825,000,000 JPY
25,010,000,000 JPY
Gross profit (loss)
29,860,000,000 JPY
30,562,000,000 JPY
Selling, general and administrative expenses
20,986,000,000 JPY
18,168,000,000 JPY
Selling, general and administrative expenses
Salaries
4,224,000,000 JPY
4,211,000,000 JPY
Operating profit (loss)
8,873,000,000 JPY
8,873,000,000 JPY
JPY
7,858,000,000 JPY
1,015,000,000 JPY
12,394,000,000 JPY
JPY
12,394,000,000 JPY
11,433,000,000 JPY
960,000,000 JPY
Non-operating income
Interest income
6,000,000 JPY
5,000,000 JPY
Dividend income
466,000,000 JPY
428,000,000 JPY
Non-operating income
522,000,000 JPY
600,000,000 JPY
Non-operating expenses
Interest expenses
13,000,000 JPY
12,000,000 JPY
Non-operating expenses
92,000,000 JPY
18,000,000 JPY
Ordinary profit (loss)
9,304,000,000 JPY
12,976,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
0 JPY
2,000,000 JPY
Extraordinary income
5,000,000 JPY
4,000,000 JPY
Extraordinary losses
Impairment losses
JPY
304,000,000 JPY
Extraordinary losses
89,000,000 JPY
338,000,000 JPY
Profit (loss) before income taxes
9,220,000,000 JPY
12,641,000,000 JPY
Income taxes
2,545,000,000 JPY
3,492,000,000 JPY
Profit (loss)
6,675,000,000 JPY
9,149,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.